The Insulin Human and Insulin Human, cataloged under National Stock Number 6505-01-356-7003, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Novo Nordisk Inc. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-356-7003 |
| Primary Part Number | NDC00003-1837-11 |
| Item Name | Insulin Human and Insulin Human |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Novo Nordisk Inc |
| Status | ACTIVE |
| Primary Container Content Quantity | 10.000 MILLILITERS |
| Primary Container Type | VIAL, MULTIPLE DOSE |
| Active Medicament Medicinal Strength | 100.000 USP UNITS INSULIN, HUMAN PER MILLILITER |
| Total Primary Container Quantity | 100 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00003-1837-11 PRIMARY | Novo Nordisk Inc (USA) |
| 1837-11 PRIMARY | Novo Nordisk Inc (USA) |
| Reference | Meaning |
|---|---|
| NOVOLIN 70/30 | 5/1 Secondary reference Novo Nordisk Inc |
| 183711 | 3/1 Design control — primary reference Novo Nordisk Inc |
NSN 6505-01-356-7003 is a Insulin Human and Insulin Human, manufactured by Novo Nordisk Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-356-7003 has 2 manufacturer part numbers on file: NDC00003-1837-11 (Novo Nordisk Inc), 1837-11 (Novo Nordisk Inc).
Key specifications for NDC00003-1837-11: Primary Container Content Quantity: 10.000 MILLILITERS; Primary Container Type: VIAL, MULTIPLE DOSE; Special Features: 70% NPH AND 30% REGULAR; RECOMBINANT DNA ORIGIN; Active Medicament Medicinal Strength: 100.000 USP UNITS INSULIN, HUMAN PER MILLILITER. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.